L-thyroxin

DRUG2 trials

Sponsors

Mikael Lantz, University of Tartu

Conditions

Graves´ DiseaseThyroid Cancer

Phase 4

Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)

CompletedNCT01458600

Mikael LantzGraves´ Disease

Start: 2006-09-30End: 2016-02-29Updated: 2016-02-24

Unknown Phase

Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer

CompletedNCT01840332

University of TartuThyroid Cancer

Start: 2013-04-30End: 2014-02-28Updated: 2014-03-14